Sheila Mathias - 27 Sep 2023 Form 3 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Signature
/s/ Sheila Mathias
Issuer symbol
VRPX
Transactions as of
27 Sep 2023
Net transactions value
$0
Form type
3
Filing time
03 Oct 2023, 09:51:37 UTC
Next filing
31 Jan 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRPX Stock Option (Right to buy) 27 Sep 2023 Common Stock 25,000 $4.62 Direct F1
holding VRPX Stock Option (Right to buy) 27 Sep 2023 Common Stock 60,676 $2.13 Direct F1
holding VRPX Stock Option (Right to buy) 27 Sep 2023 Common Stock 112,000 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata equally over three years.

Remarks:

Exhibit 24 - Power of Attorney